InvestorsHub Logo
Followers 14
Posts 737
Boards Moderated 0
Alias Born 09/13/2013

Re: None

Saturday, 11/09/2013 7:02:09 AM

Saturday, November 09, 2013 7:02:09 AM

Post# of 38475
redsox17 Saturday, 11/02/13 07:01:45 AM
Re: None
Post # of 37314

ARE WE ONLY LOOKING AT THE NEGATIVE OF THIS COMPANY?

Pharmagen Inc (OTCMKTS:PHRX) closed yesterday at $0.0049, a -26.87% decrease. Around 9.47 million shares were traded, beating an-average trading volume of 1.23 million shares. The company is now valued at around $2.58 million. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.

http://www.sbwire.com/press-releases/momentum-stocks-in-focus-sk3-group-incotcmktsskto-pharmagen-incotcmktsphrx-invivo-therapeutics-holdings-corpotcmktsnviv-overseas-shipholding-group-incotcmktsosgiq-374284.htm

Full Time Employees: 27

http://finance.yahoo.com/q/pr?s=PHRX+